What is the Y-tunnus number of Optimapharm Nordic Oy?

Optimapharm Nordic Oy is registered with PRH / YTJ under Y-tunnus 1982804-3.

What is the revenue of Optimapharm Nordic Oy?

Optimapharm Nordic Oy reported revenue of 2,6 milj. € in 2025.

Ivana Waller is the CEO of Optimapharm Nordic Oy, in role since 2023.

Ivana Waller chairs the board of Optimapharm Nordic Oy, in role since 2023.

Optimapharm Nordic Oy's registered address is Tekniikantie 12.

OYActive

Actively employed in the business

Name	Role	Member since
Current (3)
SK Stiina Kaisa Vuorio Confidential Clerk	Confidential Clerk	2024
MA Miguel Angel Salcedo Iglesias Confidential Clerk	Confidential Clerk	2023
IW Ivana Waller Chief Executive Officer	Chief Executive Officer	2023

Former (5)


EI Erika Ida Maria Grönlund Audit	Audit	2022 – 2023
TM Tarja Marjut Maria Leikas Chief Executive Officer	Chief Executive Officer	2018 – 2019
PS Pekka Sakari Hietala

Non-executive oversight

Name	Role	Member since
Current (2)
MA Miguel Angel Salcedo Iglesias Board of Directors	Board of Directors	2023
IW Ivana Waller Chairperson	Chairperson	2023

Former (8)


AC Amos Cyril David Gyllenbögel Board of Directors	Board of Directors	2019 – 2022
PH Päivi Helena Valtonen Chairperson	Chairperson	2018 – 2023
HM Harri Martti Mäkitie Board of Directors	Board of Directors	2019 – 2022

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.